Lucid Diagnostics Inc. Debt Instrument, Convertible, Conversion Price
Lucid Diagnostics Inc. (LUCD) had Debt Instrument, Convertible, Conversion Price of $0.30 per share as of 2023-03-31, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2024-11-12
- 2023-03-31: Debt Instrument, Convertible, Conversion Price $0.30.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2023-03-31 | $0.30 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |